Topiramate Adjunctive Therapy for Olanzapine Induced Weight Gain in Patients with Schizophrenia
In recent days, the prevailing use of second-generation antipsychotics (SGA) or atypical antipsychotics over conventional antipsychotics have shifted the concern of physician from extrapyramidal side effects to the weight gain in the patients receiving treatment for schizophrenia. Among others atyp...
Main Authors: | Sanjib Pandit, Asha Sharma |
---|---|
Format: | Article |
Language: | English |
Published: |
Karnali Academy of Health Sciences
2019-08-01
|
Series: | Journal of Karnali Academy of Health Sciences |
Online Access: | http://jkahs.org.np/jkahs/index.php/jkahs/article/view/96 |
Similar Items
-
Comparison of olanzapine-induced weight gain and metabolism abnormalities between topiramate and vitamin C in patients with schizophrenia: a preliminary study
by: Jinling Zhang, et al.
Published: (2023-05-01) -
Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
by: Nobuto Tsuneyama, et al.
Published: (2016-01-01) -
Treatment progress of weight gain and abnormal lipid metabolism in patients with schizophrenia caused by clozapine and olanzapine
by: Kang Li, et al.
Published: (2021-04-01) -
Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia
by: S. Bise, et al.
Published: (2022-06-01) -
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
by: Li Qian, et al.
Published: (2023-08-01)